The endoprosthesis market is set to grow a lot from 2025 to 2035. This is due to more old people, more bone diseases, and more need for new medical devices.
The market will jump from USD 32,276 million in 2025 to USD 95,858.2 million by 2035 at a yearly growth rate of 11.5%.
Endoprostheses, like joint replacements and fake limbs, help improve the lives of people with bone issues, old-age diseases, or those healing from surgery or injuries. More surgeries, especially joint replacement ones, will push the demand for these kinds of products higher.
Market Metrics
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 32,276 Million |
| Market Value (2035F) | USD 95,858.2 Million |
| CAGR (2025 to 2035) | 11.5% |
North America currently holds the largest share of the endoprosthesis market, due to an increasingly aged population and the growing prevalence of musculoskeletal disorders. The highest share in this region of the world is attributable to the United States onsidering the well-developed health care infrastructure and increased knowledge of joint renewals, along with the more excellent acceptance of advanced prosthetic technologies.
The demand for endoprostheses, particularly knee, and hip, in the region is increasing constantly attributed to the rapidly expanding geriatric population and the rising prevalence of arthritis and conditions related to osteoporosis. In addition, the strong reimbursement policies and regulatory support in the Region provide an opportunity for market growth.
Germany, the UK, and France are major contributors to this market in Europe, which had previously been dominated by the US. The region boasts robust healthcare frameworks that allow for the wide availability of state-of-the-art prosthetic devices.
Factors such as the older population, rising incidence of degenerative diseases and greater uptake of joint replacements in Europe are adding to the growth of the market. Moreover, rising expenditure for healthcare, improved and developed prosthetic techniques, and surging consumer inclination toward minimally invasive procedures are anticipated to stimulate endoprostheses demand over the forecast period.
In the coming ten years, the endoprosthesis market is anticipated to expand most rapidly in the Asia-Pacific area. The market is also being driven in this region as a result of an aging population, expanding healthcare infrastructure, and greater awareness of orthopedic procedures.
Age related musculoskeletal disorders are on the rise in countries such as China, Japan, and India, alongside the emerging middle class with access to higher services including health facilities. In addition to this, technological development and availability of cost effective healthcare solution will also facilitate the growth of market in this area.
High Costs and Surgical Risks
The endoprosthesis market has been hindered by the high costs associated with endoprosthetic procedures, which encompass the cost of implants, surgeries, and post-operative care. These high costs can leave advanced prosthetics out of reach for many, particularly in emerging markets with lower healthcare budgets.
There are also potential risks associated with these surgeries, including various infections, the failure of the implant, or adverse results from existing patient illnesses. Therefore, this poses challenges that need to be solved by the engineering method to develop reliable yet less expensive prosthetic solutions with reduced risks of surgery.
Technological Advancements and Growing Patient Base
The endoprosthesis market includes several opportunities driven primarily by the continuous improvements in prosthetic technology. These Include Newer 3D Printers, customized implants and robot-assisted surgeries that are improving post-operative outcomes of joint replacements, contributing to higher demand for sophisticated and efficient endoprosthesis.
In addition, the increasing geriatric population worldwide and the rising prevalence rate of musculoskeletal diseases provide important market access. The endoprosthesis market is continuously in their state of boom because of the rising investments by governments and private players in healthcare infrastructure and research.
Endoprosthesis market is expected to grow from 2025 to 2035. Market growth is driven by the increasing prevalence of degenerative joint diseases like osteoarthritis and rheumatoid arthritis, in addition to improvements in implant technologies and custom prosthetics.
This is improving patient outcomes and accelerating recovery times. Moreover, the low and cost involve of endoprostheses, owing to the rise in minimally invasive surgery and 3D-printed implants.
The growing population aged people across the globe is driving the growth of joint replacement surgeries, particularly hip and knee replacements, on the other hand, technology innovations related to robotic-assisted surgeries and smart prostheses is making the procedures more effective and precise.
Furthermore, there is an increasing need for biological and hybrid materials that promote proper integration of the prostheses with the human body and alleviate the complications.
Market Shifts: 2020 to 2024 vs. 2025 to 2035
| Key Dimensions | 2020 to 2024 |
|---|---|
| Product Types | Hip implants, knee implants, spinal implants, shoulder implants |
| Material Innovations | Titanium, cobalt-chromium, stainless steel |
| Technological Advancements | Manual joint replacement surgeries, traditional implants |
| Geographic Expansion | North America, Europe, parts of Asia-Pacific |
| Healthcare Trends | Focus on long-term implant durability and safety |
| Regulatory Landscape | Compliance with safety and durability standards |
| R&D Investment Focus | Improved durability and material innovation |
| Patient Demographics | Primarily elderly patients with degenerative joint diseases |
| Key Dimensions | 2025 to 2035 |
|---|---|
| Product Types | Custom-designed implants, 3D-printed prostheses, hybrid prosthetics |
| Material Innovations | Biomaterials, ceramic, polyethylene, hybrid materials |
| Technological Advancements | Robotic-assisted surgeries, smart prostheses, and AI-enhanced surgical planning |
| Geographic Expansion | Expanding in emerging markets like Southeast Asia, Latin America, and the Middle East |
| Healthcare Trends | Emphasis on personalized implants, minimally invasive surgeries, and faster recovery |
| Regulatory Landscape | Stricter regulations for advanced biomaterials and hybrid implants |
| R&D Investment Focus | 3D-printed prostheses, biologically integrated implants, and personalized solutions |
| Patient Demographics | Expanding to younger patients, athletes, and those with congenital deformities |
Endoprosthesis in the United States Market is anticipated to witness a vigorous growth with increasing prevalence of age-related joint diseases, such as osteoarthritis and rheumatoid arthritis & demand for advancement in prosthetic solution. The market is being fueled by the aging population and high healthcare expenditure in the USA.
The Endoprosthesis meets FDA (USA Food and Drug Administration) safety and efficacy standards. The emergence of modern surgical and personalized techniques, such as titanium and polyethylene, is driving the market forward as technology continues to develop.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 11.7% |
The endoprosthesis market in the UK is growing due to an increase in the elderly population that needs a joint replacement surgery and the increasing demand for advanced prosthetics. Hospitals under the National Health Service (NHS) are using more advanced and technologically capable prosthetic solutions for a graying populace.
An increasing number of regulatory authorities in the UK, including the Medicines and Healthcare products Regulatory Agency (MHRA), which is primarily aimed at guaranteeing the safety and efficacy of endoprostheses, will serve as one of the key driving forces for the expansion of the market. The growth of minimally invasive surgical methods and the development of prosthetic materials are key trends supporting market opportunities.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 11.2% |
More people need prosthetic joints because of the aging population, rising obesity, and active older folks. This leads to growth in the Endoprosthesis Market in the EU. Germany, France, and Italy are top markets due to their good health systems and access to advanced fake joint options.
In the EU, rules ensure the safety and effectiveness of fake joints, watched by groups like the European Medicines Agency (EMA) and other national bodies. Also, people are learning more about the benefits of joint surgeries, and new technology in prosthetic joints is boosting market growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 11.5% |
The Japan endoprosthesis market relevance to Growth during forecast period: joint replacement surgeries, especially hip and knee prostheses, are projected to expand as the population in Japan continues to age and degenerative joint diseases become more prevalent. Japan has a strong health care system, with a national health insurance program that's generous by world standards, and offers wide access to modern prosthetic options.
The Japan administration has a regulatory framework to regulate for safety and quality of medical devices, including endoprostheses. New materials and surgical techniques have further increased growth in the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 11.6% |
The South Korea endoprosthesis market is set to grow at an admirable compound annual growth rate (CAGR) owing to the growing demand for joint replacement surgeries, especially in the geriatric population. With the improvement of the country’s healthcare system, advanced prosthetic solutions are becoming more accessible. The South Korean government is also providing support for medical innovations such as the development of more efficient and durable prosthetic materials.
The MFDS regulates the use of endoprostheses to ensure that all endoprostheses meet rigorous safety standards. Drivers in the expansion of the market are technological advancements, like 3D-printed prosthetics and personalized implants.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 11.4% |
With an increase in the aging population, and chronic diseases rise, and as prosthetic tech gets better, the endoprosthesis market is set to grow strong from 2025 to 2035. Increasingly being used to enhance the quality of life in patients suffering from joint disorders and cardiovascular diseases, endoprosthesis products including joint prosthetics and vascular stents are rapidly being adopted in healthcare institutes.
Knee Prosthetics to Lead, Driven by the Prevalence of Osteoarthritis and Joint Disorders
| Product Type | Market Share (2025) |
|---|---|
| Knee Prosthetics | 22.1% |
As per the statistics, knee prosthetics are estimated to hold maximum percentage share around 22.1% of the endoprosthesis till the year 2025.The demand can also be attributed to increasing prevalence of osteoarthritis, age-related disorders of joint, and sports injuries and the advancements in the prosthetic materials and design. Prosthetics in this segment offer patients greater mobility and improved quality of life; thus, this segment is among the most important part of the overall market.
Hospitals to Lead, Driven by the High Demand for Complex Prosthetic Procedures
| End User | Market Share (2025) |
|---|---|
| Hospitals | 51.8% |
Based on the end user's perspective, the hospital segment is poised to account for a share of 51.8% in the endoprosthesis market in 2025. Hospitals are a vital infrastructure for advanced surgical care, everything from joint replacements to cardiovascular procedures.
With access to skilled surgeons, advanced medical technology, and postoperative care, hospitals are the most common site for endoprosthetic procedures. With increasing complex prosthetic surgeries and joint replacements and heart valve procedures an integral part of the hospital sector growth in the industry, the demand for hospital prosthetic market is expected to rise in the future.
Endoprosthesis market, comprising implants and prosthetics employed in joint replacement procedures are outpacing across multiple end users like hospitals and orthopaedics, majorly fueled by rising elderly demographics, increasing prevalence of arthritis, and improvements in plastic envelopes and technologies.
The orthopaedic and dental implants market is also seeing innovations that are aimed towards enhancing the longevity, biocompatibility, and functionality of the prostheses, with the demand for implants also increasing in parallel.
3D printing, custom implants and smart prosthetics, for example, have been technological innovations that are changing all of that. Manufacturers are now focusing on creating personalized and adaptive prosthetic solutions. This is because of the growing popularity of less invasive surgeries, endoprostheses tailored for each patient, and surgeries assisted by robots. More money spent on healthcare and good insurance policies also help the market grow in developed areas.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Stryker Corporation | 20-25% |
| Zimmer Biomet | 18-22% |
| Johnson & Johnson (DePuy Synthes) | 15-20% |
| Smith & Nephew | 12-16% |
| Medtronic (Covidien) | 8-12% |
| Other Companies (combined) | 20-25% |
| Company Name | Key Offerings/Activities |
|---|---|
| Stryker Corporation | In 2024, Stryker grew its product line with new knee and hip replacement implants that last longer and lower complication risks. They are also spending money on robotic tools for precise surgeries. |
| Zimmer Biomet | Zimmer Biomet used 3D printing in 2024 to make custom implants for better fit and life span. They also made new smart implants with sensors to check how well patients heal. |
| Johnson & Johnson (DePuy Synthes) | DePuy Synthes brought out new implants for knees and hips. These aimed to help people move better and heal faster. They are also working on surgery tools that need only small cuts. |
| Smith & Nephew | Smith & Nephew in 2024 put out new hip and knee implants. These help joints stay strong and work well for a long time. Also, they are putting money into tech to help people heal after surgery. |
| Medtronic (Covidien) | Medtronic made new dental implants in 2024 that fit each person. They are also adding more tools for spine surgeries with a focus on doing it better and helping people get well. |
Key Company Insights
Stryker Corporation (20-25%)
With a wide-ranging portfolio of various joint replacements including hip, knee, and shoulder prostheses, Stryker Corporation ranks among the top players in the endoprosthesis market. The company’s focus on robotic-assisted surgeries and personalized implant technologies uniquely prepares it for a leadership role through 2035. In 2024, Stryker became more diversified with longer-lasting, better-accommodating implants (advanced alignment) post-surgery.
Zimmer Biomet (18-22%)
Zimmer Biomet is among the leading competitors in the endoprosthesis market, specifically for knee and hip replacement implants. They have invested heavily in the 3D printing and patient-specific solutions technology, a move that improves the precision and life of the implant as well. Zimmer Biomet is also assisting to accelerate patient motion and minimize restoration time, which are the cornerstones of its enterprise in international market.
Johnson and Johnson (DePuy Synthes) (15-20%)
DePuy Synthes (a subsidiary of Johnson & Johnson) a leading player in orthopedic endoprostheses. The firm is concentrating on new materials and approaches for enhanced joint replacement results. And their more recent focus on smart implants that can natively support monitoring sensors to help with post-surgery care fits very well with the trends we are seeing toward personalized medicine.
Smith & Nephew (12-16%)
Smith & Nephew is focused on providing a broad range of implants and prosthetics, and is investing heavily in making long-term performance of joint replacements better. With a growing ability to develop products like rehabilitation technologies, in addition to its obvious strategic concentration on less invasive procedures, the company is establishing considerable competitive advantage, particularly in emerging markets.
Medtronic (Covidien) (8-12%)
Notably, the company has acquired market share with its innovative solutions in spinal and dental endoprostheses. It confirms Medtronic role as the top player in customizable implants to the patient's needs. The ongoing investment in surgical robotics and post-surgical care technology underscores the company’s BMI market position.
Other Key Players (20-25% Combined)
Several other companies are contributing to the competitive endoprosthesis landscape:
The overall market size for the endoprosthesis market was USD 32,276 million in 2025.
The endoprosthesis market is expected to reach USD 95,858.2 million in 2035.
Key drivers include the rising prevalence of joint disorders and musculoskeletal diseases and increasing demand for minimally invasive surgical procedures.
The United States, Germany, Japan, China, and India are expected to be the top contributors, driven by their healthcare systems, increasing adoption of joint replacement procedures, and rising patient awareness.
The orthopedic segment is expected to lead, particularly due to the rising demand for hip, knee, and shoulder replacements.
Explore Therapeutic Device Insights
Endoprosthesis Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
